Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zhuo-Ying Luo
Observed name:
Zhuoying Luo
Institutions:
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China
Observed institutions:
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China,
Southern Medical University
ORCID:
0000-0003-2220-1850
Observed ORCID:
0000-0003-2220-1850
OpenAlex ID:
A5017739974
Anxiety and depression in nasopharyngeal carcinoma patients and network analysis to identify central symptoms: A cross-sectional study from a high-incidence area
2024
·
Ze-Jiang Zhan
, Hao-Yang Huang
, et al.
·
Radiotherapy and Oncology
·
22
PDF
Association of polymorphisms in the catalase gene with the susceptibility to noise-induced hearing loss: A meta-analysis
2022
·
Jingyi Wu
, Zhihui Jiang
, et al.
·
American Journal of Otolaryngology
·
10
Optimal therapeutic strategies for hepatic metachronous oligometastatic nasopharyngeal carcinoma: Insights from a retrospective study
2024
·
Haoyang Huang
, Yuping Zhao
, et al.
·
International Journal of Cancer
·
9
Final survival analysis of induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by concurrent chemoradiotherapy in nasopharyngeal carcinoma: a multicenter, randomized, phase 3 trial
2026
·
Xun Cao
, Jia-Yu Zhou
, et al.
·
Nature Communications
·
2
PDF
Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
2025
·
Xun Cao
, Zhuo-Ying Luo
, et al.
·
Clinical Cancer Research
·
2
PDF
The role of immunochemotherapy maintenance in metastatic nasopharyngeal carcinoma: insights from a cohort study in an endemic region
2025
·
Zhuoying Luo
, Yue Xia
, et al.
·
Clinical & Translational Immunology
·
1
PDF
Data from Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
2025
·
Xun Cao
, Zhuo-Ying Luo
, et al.
Supplementary Method 2 from Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
2025
·
Xun Cao
, Zhuo-Ying Luo
, et al.
Supplementary Table 4 from Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
2025
·
Xun Cao
, Zhuo-Ying Luo
, et al.
Supplementary Method 1 from Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
2025
·
Xun Cao
, Zhuo-Ying Luo
, et al.
Supplementary Figure 1 from Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
2025
·
Xun Cao
, Zhuo-Ying Luo
, et al.
Supplementary Table 2 from Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
2025
·
Xun Cao
, Zhuo-Ying Luo
, et al.
Supplementary Table 7 from Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
2025
·
Xun Cao
, Zhuo-Ying Luo
, et al.
Supplementary Table 5 from Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
2025
·
Xun Cao
, Zhuo-Ying Luo
, et al.
Supplementary Table 3 from Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
2025
·
Xun Cao
, Zhuo-Ying Luo
, et al.
Supplementary Table 6 from Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
2025
·
Xun Cao
, Zhuo-Ying Luo
, et al.
Supplementary Table 1 from Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
2025
·
Xun Cao
, Zhuo-Ying Luo
, et al.
Supplementary Data 1 from Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
2025
·
Xun Cao
, Zhuo-Ying Luo
, et al.
Supplementary Table 8 from Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
2025
·
Xun Cao
, Zhuo-Ying Luo
, et al.
Optimal maintenance therapy strategy for metastatic nasopharyngeal carcinoma: Insights from a cohort study in an endemic region.
2025
·
Zhuoying Luo
, Yue Xia
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
20
Citation count:
46
H-index:
3
I10-index:
2
Year
Topic
Type